Skip to main content
. 2024 Dec 27;11(1):e41519. doi: 10.1016/j.heliyon.2024.e41519

Table 3.

Association analysis of Pre-mir-149 rs2292832 SNP with GI cancers.

Cancer Site Model OR 95 % CI p Value ORa 95 % CI pa Value ORb 95 % CI pb
Value
GIC Dominant 1.5 0.97–2.33 0.070 1.4 0.89–2.25 0.145 1.68 1.06–2.63 0.029
Recessive 0.67 0.43–1.05 0.077 0.64 0.40–1.02 0.063 0.63 0.39–1.0 0.05
TT Vs TC 1.35 0.84–2.17 0.218 1.25 0.76–2.05 0.383 1.44 0.87–2.38 0.153
TT Vs CC 1.8 1.05–3.07 0.032 1.77 1.01–3.11 0.046 2.1 1.18–3.75 0.012
T Vs C 1.38 1.04–1.82 0.024 1.37 1.02–1.83 0.036 1.47 1.1–1.97 0.009
GC Dominant 1.43 0.80–2.56 0.224 1.37 0.71–2.63 0.353 1.62 0.89–2.95 0.117
Recessive 0.73 0.40–1.33 0.301 0.74 0.38–1.43 0.369 0.73 0.4–1.34 0.307
TT Vs TC 1.32 0.71–2.48 0.383 1.27 0.63–2.56 0.499 1.5 0.78–2.89 0.226
TT Vs CC 1.63 0.80–3.32 0.177 1.61 0.74–3.49 0.23 1.82 0.87–3.82 0.111
T Vs C 1.3 0.90–1.90 0.155 1.28 0.84–1.93 0.249 1.37 0.94–2.01 0.104
CRC Dominant 1.53 0.86–2.69 0.147 1.36 0.75–2.45 0.307 1.68 0.92–3.05 0.091
Recessive 0.6 0.33–1.11 0.104 0.59 0.32–1.12 0.109 0.55 0.29–1.05 0.068
TT Vs TC 1.32 0.72–2.43 0.377 1.18 0.63–2.22 0.601 1.37 0.72–2.6 0.341
TT Vs CC 1.98 0.96–4.05 0.063 1.79 0.85–3.78 0.124 2.45 1.11–5.37 0.026
T Vs C 1.44 1–2.09 0.052 1.38 0.95–2.01 0.096 1.54 1.05–2.26 0.027
EC Dominant 2.04 0.83–5 0.121 1.84 0.73–4.6 0.195 2.32 0.87–6.16 0.092
Recessive 0.97 0.38–2.49 0.956 0.98 0.38–2.52 0.965 1.01 0.38–2.66 0.985
TT Vs TC 2.41 0.85–6.88 0.1 2.33 0.80–6.73 0.119 2.92 0.92–9.22 0.068
TT Vs CC 1.66 0.58–4.78 0.347 1.46 0.49–4.36 0.498 1.81 0.59–5.57 0.303
T Vs C 1.37 0.74–2.53 0.314 1.31 0.70–2.43 0.4 1.39 0.73–2.63 0.318
Others Dominant 1.13 0.39–3.30 0.822 1.13 0.38–3.35 0.828 1.68 0.54–5.26 0.370
Recessive 0.42 0.12–1.49 0.177 0.42 0.12–1.51 0.185 0.27 0.06–1.21 0.087
TT Vs TC 0.85 0.28–2.6 0.778 0.87 0.28–2.73 0.811 1.11 0.35–3.54 0.865
TT Vs CC 2.15 0.49–9.46 0.31 2.26 0.51–10.1 0.284 4.47 0.77–25.9 0.095
T Vs C 1.42 0.73–2.78 0.303 1.42 0.72–2.79 0.315 1.83 0.90–3.73 0.095

CI; Class Interval, OR; Crude Odds Ratio, ORa, Pa; adjusted for age and sex, ORb, Pb; adjusted for Diabetes, diet and region, p values-significant values are bold. GIC; Gastrointestinal cancers, GC; Gastric cancer, CRC; Colorectal cancer, EC; Esophageal cancer.